QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®
| Autor: | Jaffar-Aghaei, Morteza, Khanipour, Farzad, Maghsoudi, Amir, Sarvestani, Rahim, Mohammadian, Mahdi, Maleki, Maryam, Havasi, Forugh, Rahmani, Hossein, Karagah, Amir-Hossein, Kazemali, Mohammad-Reza |
|---|---|
| Zdroj: | In European Journal of Pharmaceutical Sciences 1 June 2022 173 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect